Literature DB >> 740054

Increased digitoxin cleavage by liver microsomes of spironolactone-pretreated rats.

A Schmoldt.   

Abstract

Pretreatment of rats with spironolactone caused an fourfold increased cleavage rate of the sugar chain of digitoxin (dt-3) in vitro yielding digitoxigenin-bis-digitoxoside. This was due to an enhanced, cyt. P450 dependent, formation of 15'-dehydro-dt-3, the intermediate which has to be formed before the terminal sugar can be split off. The second reaction catalysed by microsomal monoxygenases, the 12-beta-hydroxylation, was only increased by a factor 2. In contrast to the effects of spironolactone no increase of metabolism could be observed after phenobarbital pretreatment. From our results it may be concluded that the enhanced dt-3 metabolism in vivo is mainly caused by spironolactone inducible monoxygenases which catalyse the oxidation of the terminal sugar.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 740054     DOI: 10.1007/bf00498820

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.

Authors:  H F VOHRINGER; L Weller; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.

Authors:  D R Feller; M C Gerald
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

4.  Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.

Authors:  C D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  1974-11       Impact factor: 4.030

5.  Cleavage by beta-glucuronidase of the water-soluble metabolites of digitoxin excreted in the bile of control and spironolactone-pretreated rats.

Authors:  M C Castle; G L Lage
Journal:  Toxicol Appl Pharmacol       Date:  1974-03       Impact factor: 4.219

6.  Biliary excretion of 3 H-digitoxin: modification by bile salts and phenobarbital.

Authors:  N J Greenberger; F B Thomas
Journal:  J Lab Clin Med       Date:  1973-02

7.  Enhanced biliary excretion of digitoxin following sprionolactone as it relates to the prevention of digitoxin toxicity.

Authors:  M C Castle; G L Lage
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-01

8.  The effect of spironolactone on drug metabolism by hepatic microsomes.

Authors:  B Stripp; M E Hamrick; N G Zampaglione; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

9.  Stimulation of the glucuronidation of digitoxigenin-monodigitoxoside by liver homogenates from spironolactone-pretreated rats.

Authors:  L G Richards; G L Lage
Journal:  Toxicol Appl Pharmacol       Date:  1977-11       Impact factor: 4.219

10.  Proceedings: Comparison of liver enzyme induction by polychlorinated biphenyls (PCB) and phenobarbital studied for digitoxin metabolism in rats.

Authors:  A Schmoldt; H F Benthe; W Grote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

View more
  2 in total

1.  Cleavage of digoxigenin digitoxosides by rat liver microsomes.

Authors:  A Schmoldt; B Ahsendorf
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

2.  Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man.

Authors:  A Schmoldt; I Blömer; A Johannes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.